A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.

Diğer sürümleri göster (1)

We used baseline data from the NAVIGATOR trial to (1) identify risk factors for diabetes progression in those with impaired glucose tolerance and high cardiovascular risk, (2) create models predicting 5-year incident diabetes, and (3) provide risk classification tools to guide clinical interventions...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Bethel, M, Chacra, A, Deedwania, P, Fulcher, G, Holman, R, Jenssen, T, Kahn, SE, Levitt, N, McMurray, J, Califf, R, Raptis, SA, Thomas, L, Sun, J, Haffner, S
Materyal Türü: Journal article
Dil:English
Baskı/Yayın Bilgisi: 2013

Benzer Materyaller